We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Ever COVID-19 Portable Sweat Test Device Delivers Results in 30 Seconds

By LabMedica International staff writers
Posted on 13 Sep 2021
Print article
Image: The Portable Sweat Test Device for COVID-19 (Photo courtesy of Chulalongkorn University)
Image: The Portable Sweat Test Device for COVID-19 (Photo courtesy of Chulalongkorn University)
A first-ever COVID-19 portable sweat test device can yield instant results and could support proactive screening in the community.

Researchers at Chulalongkorn University (Bangkok, Thailand) have successfully developed, for the first time, a quick and easy-to-use portable sweat test device for COVID-19 to detect specific scents in sweat caused by bacteria. Sample collection only takes 15 minutes per person, and the results can be obtained in 30 seconds. The sweat test is now being used in community screening. The test is based on the success of the “COVID-19 Sniffer Dogs” project that uses sweat sniffer dogs to detect asymptomatic COVID-19 cases in the community.

People’s sweat may have more than 100 unique scents — be it from the powder, roll-on deodorant, or the bacteria that feed on sweat or skin secretions, then excrete the substances that are mixed with sweat. The portable sweat test device was developed from a commercially available portable chemistry analyzer which is generally used to measure chemicals that are toxic to the environment. To adapt it to detect COVID-19, the researchers installed a specific filter to detect the virus. The advantage of this method is that it can be adapted to detect mutated variants of the virus or other microorganisms. Field tests of the device on 2,000 people alongside the PCR (Polymerase Chain Reaction) testing found the results to be on a par – with 95% sensitivity and 98% specificity.

“For those infected with COVID-19, the bacteria react abnormally to the virus and produce some distinct odors unique to COVID-19 infection,” explained Asst. Prof. Dr. Chadin Kulsing, Department of Chemistry, Faculty of Science, Chulalongkorn University. “The test kit consists of a glass vial and a cotton swab which screeners will receive one each. The screeners would place the cotton swab under the armpit of the person receiving the test and leave it for about 15 minutes. After that, the cotton swab is put in the glass vile, which is then sterilized with UV rays. The technician then draws an appropriate amount of the sample using a suction hose, and pressurizes it into the analyzer to check the results.”

Related Links:
Chulalongkorn University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more